Global Market Research Group

"Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype. NSCLC patients are usually diagnosed in the later stages of the disease, with poor prognosis. Historically, treatment options for advanced-stage NSCLC patients have been dominated by chemotherapy. However, the launch of targeted therapies such as Iressa (gefitinib) in 2003, Tarceva (erlotinib) in 2004, and Xalkori (crizotinib) in 2011, has shifted the treatment landscape towards personalized medicine. Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=915842 In 2015, the NSCLC market in China was an estimat

Non-Small Cell Lung Cancer Albany, New York, May 04, 2017 "Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- ** Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident cases, approximately 85% are the non-small cell lung cancer (NSCLC) subtype. NSCLC patients are usually diagnosed in the later stages of the disease, with poor prognosis. Historically, treatment options for advanced-stage NSCLC patients have been dominated by chemotherapy. However, the launch of targeted therapies such as Iressa (gefitinib) in 2003, Tarceva (erlotinib) in 2004, and Xalkori (crizotinib) in 2011, has shifted the treatment landscape towards personalized medicine. Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid

"EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2025" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Lung cancer is a disease of uncontrolled cell growth in the lung tissues. It is one of the most commonly occurring cancers in the world (IARC, 2016). Lung cancer is classified into three main types: non-small cell lung cancer (NSCLC), small cell lung cancer, and lung carcinoid tumor. NSCLC is the most common type of lung cancer, making up about 85% of all lung cancers. Small cell lung cancer accounts for 10-15% of lung cancers, while carcinoid tumors are the rarest, occurring in fewer than 5% of lung cancers. Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=901140 In the 8MM, the diagnosed incident cases of NSCLC will increase from 791,563 cases in 2015 to 1,069,516 cases in 2025, at an Annual Growth Rate (A